Skip to main content
. 2023 Apr;255:42–49. doi: 10.1016/j.jpeds.2022.09.057

Table IV.

Demographics for post cardiopulmonary exercise testing assessment

Preterm born (all) n = 123 Preterm born fetal growth restriction n = 21 Preterm born AGA n = 102 Term born n = 54
Current Status
 Sex (male), n(%) 60 (48.8) 6 (28.6)∗ 54 (52.9) 25 (46.3)
 Ethnicity (white), n(%) 115 (93) 19 (90.5) 96 (94.1) 53 (98)
 Age at testing (y), mean (SD) 11.1 (1.2)## 11.0 (1.3) 11.1 (1.3) 10.5 (1.1)
 Height (cm), mean (SD) 146.1 (10.4) 142.0 (12.1) 146.9 (9.9) 144.5 (9.8)
 Height (z-score), mean (SD) 0.3 (1.0) −0.32 (1.06)∗†† 0.38 (0.94) 0.51 (1.02)
 Weight (kg), mean (SD) 39.8 (10.8) 36.2 (10.9) 40.6 (10.7) 39.0 (11.1)
 Weight (z-score), mean (SD) 0.3 (1.1) −0.21 (1.30)∗ 0.45 (1.08) 0.6 (1.0)
 Mass index (z-score), mean (SD) 0.22 (1.31) −0.13 (1.50) 0.30 (1.26) 0.42 (1.11)
 FMI (kg/m2), mean (SD) 4.1 (2.2) 4.01 (2.04) 4.11 (2.30) 4.06 (2.26)
 Fat free mass index (kg/m2), mean (SD) 14.3 (1.6) 13.67 (1.65) 14.45 (1.56) 14.40 (1.36)
Neonatal history
 Gestational age (wk), mean (SD) 30.5 (2.8)### 29.67 (2.33)††† 30.65 (2.89)‡‡‡ 40.00 (1.15)
 Birthweight (g), mean (SD) 1593 (576)### 987 (333.0)∗∗∗††† 1718 (535.4)‡‡‡ 3537 (484.8)
 Birthweight (z-score), mean (SD) 0.1 (1.3) −1.83 (0.69)∗∗∗††† 0.50 (0.98) 0.12 (0.89)
 Antenatal smoking, n(%) 12 (10) 3 (14.3) 9 (8.8) 1 (2.0)
Chronic lung disease of prematurity, n (%) 34 (28)### 5 (23.8)††† 29 (28.4)‡‡‡ 0 (0)
 Patent ductus arteriosus, n (%) 11 (9)# 2 (9.5) 9 (8.8)‡‡ 0 (0)
 Necrotizing enterocolitis, n (%) 7 (6) 1 (4.8) 6 (5.9) 0 (0)
 Retinopathy of prematurity, n (%) 8 (7) 1 (4.8) 7 (6.9) 0 (0)
 Intraventricular haemorrhage, n (%) 16 (13)## 2 (9.5) 14 (13.8)‡‡ 0 (0)

Preterm-born vs Term-born: #P < .05, ##P < .01, ###P < .001.

Preterm-born fetal growth restriction vs Preterm-born AGA: ∗P < .05, ∗∗P < .01, ∗∗∗P < .001.

Preterm-born fetal growth restriction vs Term-born: †P < .05, ††P < .01, †††P < .001.

Preterm-born AGA vs Term-born: ‡P < .05, ‡‡P < .01, ‡‡‡P < .001.

Antenatal smoking data missing for 2 preterm-born AGA subjects.